Financial Advisory Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$787K Sell
4,322
-26
-0.6% -$4.74K 0.14% 50
2023
Q4
$674K Buy
4,348
+100
+2% +$15.5K 0.13% 54
2023
Q3
$633K Hold
4,248
0.13% 54
2023
Q2
$572K Hold
4,248
0.11% 54
2023
Q1
$677K Hold
4,248
0.14% 52
2022
Q4
$687K Sell
4,248
-138
-3% -$22.3K 0.15% 51
2022
Q3
$589K Hold
4,386
0.13% 52
2022
Q2
$672K Hold
4,386
0.14% 51
2022
Q1
$711K Buy
4,386
+63
+1% +$10.2K 0.14% 51
2021
Q4
$585K Buy
4,323
+173
+4% +$23.4K 0.12% 53
2021
Q3
$448K Hold
4,150
0.1% 56
2021
Q2
$467K Hold
4,150
0.11% 53
2021
Q1
$449K Hold
4,150
0.11% 53
2020
Q4
$445K Hold
4,150
0.12% 53
2020
Q3
$363K Sell
4,150
-40
-1% -$3.5K 0.12% 52
2020
Q2
$411K Buy
4,190
+140
+3% +$13.7K 0.14% 48
2020
Q1
$309K Sell
4,050
-75
-2% -$5.72K 0.1% 50
2019
Q4
$365K Hold
4,125
0.1% 56
2019
Q3
$312K Sell
4,125
-600
-13% -$45.4K 0.09% 57
2019
Q2
$323K Buy
4,725
+625
+15% +$42.7K 0.09% 58
2019
Q1
$330K Buy
4,100
+100
+3% +$8.05K 0.09% 54
2018
Q4
$369K Hold
4,000
0.11% 50
2018
Q3
$378K Hold
4,000
0.1% 47
2018
Q2
$371K Buy
4,000
+300
+8% +$27.8K 0.1% 49
2018
Q1
$350K Buy
3,700
+100
+3% +$9.46K 0.11% 48
2017
Q4
$348K Buy
3,600
+200
+6% +$19.3K 0.1% 50
2017
Q3
$302K Sell
3,400
-100
-3% -$8.88K 0.1% 52
2017
Q2
$254K Buy
3,500
+200
+6% +$14.5K 0.09% 58
2017
Q1
$215K Sell
3,300
-350
-10% -$22.8K 0.07% 58
2016
Q4
$229K Buy
3,650
+150
+4% +$9.41K 0.09% 57
2016
Q3
$221K Hold
3,500
0.09% 55
2016
Q2
$217K Buy
+3,500
New +$217K 0.11% 52
2016
Q1
Sell
-3,850
Closed -$228K 60
2015
Q4
$228K Buy
+3,850
New +$228K 0.11% 50